Gluten-free Diet Monitoring in Urine

NCT02344758 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2015-01-26

No results posted yet for this study

Summary

The purpose of this study is to develope a novel method to determine gluten intake and to check gluten-free diet adherence in celiac patients by detection of gluten immunogenic peptides in urine.

Conditions

Interventions

DEVICE

Non-invasive lateral flow test for monitoring gluten intake

BEHAVIORAL

gluten-free diet (GFD)

BEHAVIORAL

gluten-containing diet

Sponsors & Collaborators

  • Instituto Hispalense de Pediatría

    collaborator UNKNOWN
  • Hospitales Universitarios Virgen del Rocío

    collaborator OTHER
  • University of Seville

    lead OTHER

Principal Investigators

  • Mª de Lourdes Moreno Amador, Dr · Department of Microbiology and Parasitology, University of Sevilla, Spain

  • Ángel Cebolla Ramírez, Dr · Biomedal S.L.

  • Ángeles Pizarro Moreno, Dr · Unidad Clínica de Aparato Digestivo, Hospital Universitario Virgen del Rocío, Sevilla, Spain

  • Alba Muñoz Suano, Dr · Biomedal, S.L., Sevilla, Spain

  • Isabel Comino Montilla, Dr · Department of Microbiology and Parasitology, University of Sevilla, Spain

  • Alfonso Rodríguez Herrera, Dr · Unidad de Gastroenterología y Nutrición, Instituto Hispalense de Pediatría. Sevilla, Spain

  • Francisco León, Dr · Celimmune, Bethesda, MD, USA

  • Carolina Carrillo Carrión · Biomedal, S.L., Sevilla, Spain

  • Carolina Sousa Martín, Professor · Department of Microbiology and Parasitology, University of Sevilla, Spain

Study Design

Allocation
RANDOMIZED
Model
PARALLEL

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-07-31
Completion
2013-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02344758 on ClinicalTrials.gov